India Panel Says Popular Metamizole Painkiller Over-Promoted By Pharmas
This article was originally published in PharmAsia News
Executive Summary
The decades-old painkiller metamizole, marketed in India as Baralgan-M, Novalgin and Analgin, was lambasted in a parliamentary committee’s report as over-promoted at home at the same time it is banned in several countries, including the U.S.